RxSight (RXST) Receivables - Net (2020 - 2026)

RxSight (RXST) has reported Receivables - Net for 7 consecutive years, with $18.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Receivables - Net fell 34.0% year-over-year to $18.5 million; the trailing twelve-month figure through Jun 2026 stood at $18.5 million (down 34.0% YoY), and the FY2025 full-year result was $23.4 million, down 22.19% from the prior year.
• Receivables - Net eased to $18.5 million in Q2 2026 per RXST's latest filing, from $22.4 million in the prior quarter.
• Across five years, Receivables - Net topped out at $31.0 million in Q1 2025 and bottomed at $5.6 million in Q1 2022.
• Historically, Receivables - Net has averaged $19.1 million across 5 years, with a median of $20.9 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Receivables - Net jumped 125.34% in 2022, then plunged 34.0% in 2026.
• Over 5 years, Receivables - Net stood at $11.0 million in 2022, then jumped by 85.11% to $20.3 million in 2023, then jumped by 48.17% to $30.0 million in 2024, then slipped by 22.19% to $23.4 million in 2025, then declined by 20.8% to $18.5 million in 2026.
• According to Business Quant data, Receivables - Net over the past three periods registered $18.5 million, $22.4 million, and $23.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.